ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,025Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 198

$458K Total Retail Price of All Prescriptions

Rank: 72 out of 198

297 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 297 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 297 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,519 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 520 500 1 1
AMLODIPINE BESYLATE 374 362 2 4
FUROSEMIDE 356 345 3 5
SIMVASTATIN 313 311 4 2
POTASSIUM CHLORIDE 301 290 5 9
OMEPRAZOLE 301 297 5 3
WARFARIN SODIUM 289 286 7 7
METOPROLOL TARTRATE 208 208 8 10
METFORMIN HCL 208 205 8 13
TRAMADOL HCL 194 181 10 15
ALENDRONATE SODIUM 185 178 11 21
ATORVASTATIN CALCIUM 185 182 11 12
LOSARTAN POTASSIUM 180 178 13 18
SERTRALINE HCL 169 169 14 25
PREDNISONE 158 153 15 29
GABAPENTIN 150 147 16 14
HYDROCODONE-ACETAMINOPHEN 147 143 S3 17 8
LISINOPRIL 147 134 17 6
POLYETHYLENE GLYCOL 3350 129 121 19 41
METOPROLOL SUCCINATE 128 128 20 11
ATENOLOL 119 114 21 17
ENALAPRIL MALEATE 109 109 22 51
RANITIDINE HCL 95 83 23 54
CARBIDOPA-LEVODOPA 91 90 24 71
CARVEDILOL 89 77 25 24
TRIAMTERENE-HCTZ 89 89 25 32
ISOSORBIDE MONONITRATE ER 87 87 27 60
CITALOPRAM HBR 86 86 28 20
DIOVAN 85 72 29 34
LANTUS 69 43 30 46
DONEPEZIL HCL 68 68 31 28
CRESTOR 67 54 32 26
HYDROCHLOROTHIAZIDE 66 66 33 16
ROPINIROLE HCL 66 66 33 74
DIGOXIN 64 59 35 43
ALLOPURINOL 64 64 35 23
LOVASTATIN 63 63 37 70
MIRTAZAPINE 63 63 37 44
LIPITOR 59 59 39 116
CLOPIDOGREL 57 57 40 42
NITROFURANTOIN 56 45 41 213
BISOPROLOL FUMARATE 54 54 42 87
TRAZODONE HCL 53 51 43 50
LOSARTAN-HYDROCHLOROTHIAZIDE 51 51 44 49
RAMIPRIL 51 51 44 72
PAROXETINE HCL 51 51 44 65
FENTANYL 51 51 S2 44 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.